Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
BIIB

Biogen

$313.22

-1.41 (-0.45%)

07:53
12/18/18
12/18
07:53
12/18/18
07:53
Recommendations
Biogen analyst commentary at Oppenheimer »

Biogen price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Yesterday
BIIB

Biogen

$314.93

0.3 (0.10%)

, ALKS

Alkermes

$33.30

0.52 (1.59%)

10:16
12/17/18
12/17
10:16
12/17/18
10:16
Recommendations
Biogen, Alkermes analyst commentary at Piper Jaffray »

Piper says Biogen's…

BIIB

Biogen

$314.93

0.3 (0.10%)

ALKS

Alkermes

$33.30

0.52 (1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

  • 31

    Jan

ALKS

Alkermes

$32.78

-1 (-2.96%)

, BIIB

Biogen

$314.63

-5.49 (-1.72%)

07:48
12/17/18
12/17
07:48
12/17/18
07:48
Hot Stocks
Alkermes, Biogen announce diroximel fumarate NDA submitted to FDA »

Alkermes (ALKS) and…

ALKS

Alkermes

$32.78

-1 (-2.96%)

BIIB

Biogen

$314.63

-5.49 (-1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

  • 31

    Jan

ALKS

Alkermes

$32.78

-1 (-2.96%)

, BIIB

Biogen

$314.63

-5.49 (-1.72%)

07:32
12/17/18
12/17
07:32
12/17/18
07:32
Hot Stocks
Alkermes; Biogen: Alkermes submits NDA to FDA for diroximel fumarate »

Alkermes (ALKS) and…

ALKS

Alkermes

$32.78

-1 (-2.96%)

BIIB

Biogen

$314.63

-5.49 (-1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

  • 31

    Jan

Thursday
AGTC

Applied Genetic

$6.61

0.54 (8.90%)

, BIIB

Biogen

$322.54

2.69 (0.84%)

07:01
12/13/18
12/13
07:01
12/13/18
07:01
Downgrade
Applied Genetic, Biogen rating change at BMO Capital »

Applied Genetic…

AGTC

Applied Genetic

$6.61

0.54 (8.90%)

BIIB

Biogen

$322.54

2.69 (0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

Wednesday
AGTC

Applied Genetic

$6.61

0.54 (8.90%)

, BIIB

Biogen

$323.73

3.88 (1.21%)

16:06
12/12/18
12/12
16:06
12/12/18
16:06
Hot Stocks
Applied Genetic reports interim data from rAAV2tYF-CB-hRS1 trial »

Applied Genetic (AGTC)…

AGTC

Applied Genetic

$6.61

0.54 (8.90%)

BIIB

Biogen

$323.73

3.88 (1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

BIIB

Biogen

$319.85

0.22 (0.07%)

07:55
12/12/18
12/12
07:55
12/12/18
07:55
Conference/Events
Biogen to hold a conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

BIIB

Biogen

$319.85

0.22 (0.07%)

04:55
12/12/18
12/12
04:55
12/12/18
04:55
Conference/Events
Biogen to hold a conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

Over a week ago
BIIB

Biogen

$319.85

0.22 (0.07%)

16:58
12/11/18
12/11
16:58
12/11/18
16:58
Conference/Events
Biogen to hold a conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

BIIB

Biogen

$322.54

-9.8 (-2.95%)

, IONS

Ionis Pharmaceuticals

$55.99

-3.57 (-5.99%)

07:42
12/06/18
12/06
07:42
12/06/18
07:42
Hot Stocks
Biogen exercises license to BIIB067 from Ionis Pharmaceuticals for $35M »

Biogen (BIIB) and Ionis…

BIIB

Biogen

$322.54

-9.8 (-2.95%)

IONS

Ionis Pharmaceuticals

$55.99

-3.57 (-5.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 12

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.